First Time Order Discount 15% (Code: BEST PEPTIDE)

Search

In Stock

IGF 1 LR3

Also known as insulin-like growth factor LR3, IGF-1 LR3 is actually a peptide with a similar chemical structure to insulin. Naturally, IGF-1 LR3 is produced in the liver and is responsible for primary growth and development, especially during childhood.

 

As the name suggests, IGF-1 LR3 binds to the IGF receptors, present in many cells, which promotes cell proliferation, differentiation and overall cell growth. These receptors are present in the majority of the cells in our body, including bone, muscle, and cartilage.

 

Though we’ve been talking strictly about IGF-1 LR3, it’s important to note and make the distinction that IGF-1 exists as well. But unlike the LR3 variant, its bind with the receptors is much stronger which is why it remains in the bloodstream a lot less. Making the LR3 variant more readily available, for longer periods of time and much more stable.

CAD $285.00CAD $420.00

Clear
SKU:N/A

Insulin-like growth factor 1 LR3 (IGF-1 LR3) from PeptideShop comes in vials of 3 mg and has to be reconstituted prior use. This peptide is synthetic and chemically altered to have a longer-half life, be more effective, and essentially increase its biological activity.

So, the story of IGF-1 LR3 begins with IGF.

It’s one of the primary growth hormone (GH) mediators , a hormone that promotes cell growth and differentiation during the formative childhood years, and continues to have an anabolic effect in adulthood.

IGF-1 peptide is a 70 amino acid long chain, structurally similar to insulin and, more importantly, capable of binding to the insulin receptors within the body. Once GH is secreted in the anterior pituitary gland, IGF-1 also gets released into the bloodstream and reaches basically every cell in the human body.

There, along with additional chemical compounds, promotes cellular growth and survival, while preventing cell apoptosis (a kind of cellular death). As such, IGF-1 became greatly important due to its role in tissue homeostasis.

IGF-1 LR3 and Cell Division

Just like naturally produced IGF-1, IGF-1 LR3 is also considered to be a potent cell division and proliferation stimulant. It mostly targets bone and muscle cells, cells of the connective tissue, but also the building blocks of lungs and blood vessels.

But, unlike IGF-1, the LR3 variant remains in the bloodstream longer (due to its altered structure), making it a more potent stimulant; in fact, in vitro studies showed that one dosage of IGF-1 LR3 is three times more potent, as compared to IGF-1 in a similar dosage.

Speaking of medical studies, they showed that IGF-1 does not lead to mear cell hypertrophy (cell enlargement), it actually boosts cell division. For this very reason, it became an interesting compound. Of course, we still need more scientific studies with human test subjects to evaluate the full effects on the body.

IGF-1 LR3 And Fat Metabolism

In the previous section, we mentioned IGF-1’s benefits on muscle cells, and now we’re going to take a closer look at its fat metabolism properties. As studies have shown, fat binds to both IGF-1 and Insulin receptors in the body; this binding action increases blood glucose uptake in cells through the body, resulting in overall dropped sugar blood levels. This action then indirectly leads to the breakdown of adipose tissue in the liver.

Of course, this reduction in blood glucose levels is what’s interesting in diabetes research and scientists are now trying to figure out how to best use IGF-1 LR3’s action in the fight to manage diabetes more effectively.

IGF-1 LR3 And Myostatin Regulation

Myostatin is a protein found exclusively in the skeletal muscles (muscles used for movement), which regulates hypertrophy and muscle cell differentiation. This is especially important in healing injuries.

But in an event of a disease (various types of muscle dystrophies) where a person experiences muscle loss, IGF-1 LR3 is seen as a myostatin stimulator, with the potential to turn the disease outcome around – slow down muscle loss, and help the patient maintain their strength and mobility.

Though we don’t yet have any definitive results from human studies, studies on mice showed promising results. Thanks to its longer half life, IGF-1 LR3 was able to counteract the negative effects of the disease – stimulate myostatin, protect muscle cells and even prevent cell death.

IGF-1 LR3 And Longevity

Knowing that IGF-1 LR3 helps with wound healing, researchers turned their attention to longevity and long-term cell damage protection. Once again, we don’t have many human studies dealing with this problem, but studies done on cow and pig test subjects showed that administering this peptide can offset cellular aging.

A related mice study was aimed at finding out if LR3-based therapy can slow down the progression of diseases such as dementia, muscle atrophy and kidney disease. We are still waiting for the results of this study, but the initial findings are promising.

Weight

3mg, 5mg

Bestsellers

Retatrutide

CAD $130.00CAD $250.00
Retatrutide, also known as LY3437943, is a glucagon-like peptide 1 agonist; what separates this peptide from the others is it also targets gastric inhibitory polypeptide receptor (GIPR) and glucagon receptors (GCGR), making it a triagonist. In the lab settings, Retatrutide mimics the natural glucagon and glucose production within the hepatocytes, while inducing lipolysis in the adipocytes.

Tesamorelin

CAD $70.00CAD $125.00
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog. It was based on the 44 amino acids sequence of GHRH and contains a trans-3 hexenoic group to protect it from enzymatic degradation. These modifications allow it to be more stable and have a longer half-life.   Just like Sermorelin, Ipamorelin or GHRP-2, Tesamorelin is considered a growth hormone secretagogue (GHS) which stimulates the secretion of GH and increases the level of insulin-like growth factor (IGF-1). The importance of IGF-1 is it tends to be lower in patients with obesity, diabetes and especially in those with lipodystrophy. References: 
  1. Sinha DK, Balasubramanian A, Tatem AJ, Rivera-Mirabal J, Yu J, Kovac J, Pastuszak AW, Lipshultz LI. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Transl Androl Urol. 2020 Mar;9(Suppl 2):S149-S159. doi: 10.21037/tau.2019.11.30. PMID: 32257855; PMCID: PMC7108996.

Oxytocin 10mg

CAD $67.00
Oxytocin is a naturally occurring, cyclic nonapeptide which acts as a neurotransmitter in the brain. This naturally occurring peptide is vital in many functions concerning reproduction and birth, it’s the principal uterine-contracting and milk-ejecting hormone.   An interesting thing about Oxytocin is that it’s one of the few hormones that exhibit a positive feedback loop; in other words, the release of oxytocin kicks certain actions in motions, which promote even more oxytocin release. References:
  1. https://www.bjanaesthesia.org/article/S0007-0912(17)33682-6/pdf
  2. https://www.sciencedirect.com/science/article/pii/S2667174324001083
  3. https://pmc.ncbi.nlm.nih.gov/articles/PMC5404956/

Semaglutide

CAD $105.00CAD $190.00
This is a synthetic peptide modeled after the naturally occurring hormone glucagon-like peptide-1 (GLP-1). GLP-1 is an incretin, a gut-derived peptide secreted in response to a meal, that regulates insulin secretion based on glucose levels in the blood. This GLP-1 agonist was developed specifically to have an extended half-life without losing potency. Since it falls under the category of glucagon-like peptide-1 receptor agonists, it acts to prompt the body to secrete more insulin and inhibit glucagon secretion. By allowing the body to secrete more insulin and inhibiting the secretion of glucagon, this joint effort brings blood glucose levels down.

AOD9604

CAD $50.00CAD $90.00
AOD9604 is a derivative of human growth hormone (hGH) and a modified version of the hGH fragment 176-191 peptide, incorporating a di-sulfide bridge. What’s exciting about this peptide is that it does not affect IGF-1 or insulin levels and is, therefore, not a risk in promoting glucose intolerance.

BPC 157 10mg

CAD $134.00
Body protection compound 157, or BPC-157, is an overall body protection compound fragment that’s 15 amino acids long, falling under the pentadecapeptide category. BPC-257 is derived from the gastric juice and, as such, is much more stable and, above all, resilient to the destructive enzymes commonly found in the gastric juice.   Research around BPC-157 showed its incredible cytoprotective properties, as it provides cell protection against gastric mucosal injury. Researchers believe this peptide plays an important role in the brain-gut axis and enables this communication between our central nervous and endocrine systems.     References:
  1. BPC-157 also interacts with dopamine, glutamate but it also helps with the upregulation of growth factors and may affect growth hormone secretion.
  2. Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019 Aug;377(2):153-159. doi: 10.1007/s00441-019-03016-8. Epub 2019 Mar 27. PMID: 30915550.
  3. Chang CH, Tsai WC, Hsu YH, Pang JH. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. 2014 Nov 19;19(11):19066-77. doi: 10.3390/molecules191119066. PMID: 25415472; PMCID: PMC6271067.

Sermorelin 10mg

CAD $120.60
Sermorelin is a 29 amino acid human growth hormone-releasing hormone (GHRH) analogue and it’s actually the shortest synthetic peptide with full GHRH biological activity. It’s considered a growth hormone secretagogue (GHS) which was initially developed only to test the secretion of GH.   What sermorelin essentially does is it mimics the hypothalamic peptide GHRH and acts directly on the pituitary gland stimulating the production of GH. It also increases the proliferation of somatotroph cells’ ability to secrete HGH. Source:
  1. Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clin Interv Aging. 2006;1(4):307-8. doi: 10.2147/ciia.2006.1.4.307. PMID: 18046908; PMCID: PMC2699646.
Back to Top
Product has been added to your cart